Abstract
A heterozygous T183A mutation in the prion protein (PrP) gene, PRNP, was identified in a patient with histopathologically confirmed spongiform encephalopathy. Clinically, this form of prion disease was characterized by early-onset dementia as the predominant sign, along with global cerebral atrophy and hypometabolism. The age at onset was 40 years and the disease duration was 4 years. Additional neurological signs including cerebellar ataxia and EEG abnormalities were absent until late stages of the disease. The T183A mutation was not found in non-affected family members. This mutation results in the removal of one of the two consensus sites for glycosylation of PrP. Neuropathological examination revealed severe spongiform degeneration and neuronal loss in the neocortex, putamen and claustrum, small plaque-like PrP-immunoreactive deposits in the molecular layer of the cerebellum, and faint intracellular cytoplasmic PrP immunoreactivity. Western blot analysis of the patient’s brain tissue showed protease K-resistant PrP with a definite preponderance of the monoglycosylated form. The additional appearance of a band representing diglycosylated PrPSc strongly suggests that non-mutated PrP also acquires protease resistance in the present setting. Cell culture experiments confirmed previous reports on intracellular retention of the mutant protein in vitro. This is the second report of a disease-causing T183A mutation of PrP, and the clinical, histological and genetic observations strongly suggest that T183A is a disease-causing mutation.
Similar content being viewed by others
References
Boellaard JW, Doerrschott J, Schlote W (1993) Miniplaques and shapeless cerebral amyloid deposits in a case of Gerstmann-Straussler-Scheinker’s syndrome. Acta Neuropathol 86:532–535
Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887–890
Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB (2000) The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. J Alzheimers Dis 2:27–35
Chen SG, Parchi P, Brown P, Capellari S, Zou W, Cochran EJ, Vnencak-Jones CL, Julien J, Vital C, Mikol J, Lugaresi E, Gambetti P (1997) Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med 3:1009–1015
Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, Baker H, Crow TJ, Lofthouse R, Poulter M, Ridley R, et al (1992) Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 115:687–710
DeArmond S, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB (1997) Selective neuronal targeting in prion disease. Neuron 19:1337–1348
DeArmond SJ, Bouzamondo E (2002) Fundamentals of prion biology and diseases. Toxicology 181–182:9–16
Finckh U, ller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W, Binetti G, Alberici A, Hock C, Nitsch RM, Gal A (2000) High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet 66:110–117
Fisher CL, Pei GK (1997) Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23:570–574
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med 2:59–64
Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, Tagliavini F (1995) Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol 5:61–75
Goldfarb LG, Petersen RB, Tabaton M, Brown P, Leblanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Gajdusek DC, Lugaresi E, Gambetti P (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808
Hainfellner J-A, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H (1999) A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 45:812–815
Hamasaki S, Shirabe S, Tsuda R, Yoshimura T, Nakamura T, Eguchi K (1998) Discordant Gerstmann-Straussler-Scheinker disease in monozygotic twins. Lancet 352:1358–1359
Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, Ironside JW, Collinge J (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:1333–1346
Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421
Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688–3693
Klebe RJ, Ruddle FH (1969) Neuroblastoma: cell culture analysis of a differentiating stem cell system. J Cell Biol 43:69a
Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582
Kretzschmar HA, Sethi S, Foldvari Z, Windl O, Querner V, Zerr I, Poser S (2003) Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol 13:245–249
Lehmann S, Harris DA (1997) Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem 272:21479–21487
Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258–3267
Lorenz H, Windl O, Kretzschmar HA (2001) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516
Luhrs T, Riek R, Guntert P, Wuthrich K (2003) NMR structure of the human doppel protein. J Mol Biol 326:1549–1557
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944
Negro A, Ballarin C, Bertoli A, Massimino ML, Sorgato MC (2001) The Metabolism and imaging in live cells of the bovine prion protein in its native form or carrying single amino acid substitutions. Mol Cell Neurosci 17:521–538
Nitrini R, Rosemberg S, Passos-Bueno MR, Teixeira da Silva LS, Iughetti P, Papadopoulos M, Carrilho PM, Caramelli P, Albrecht S, Zatz M, et al. (1997) Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 42:138–146
Nixon R, Camicioli R, Jamison K, Cervenakova L, Mastrianni JA (2000) The PRNP-V180I mutation is associated with abnormally glycosylated PrP and intracellular PrP accumulations. Brain Pathol 10:670
Owen F, Poulter M, Shah T, Collinge J, Lofthouse R, Baker H, Ridley R, McVey J, Crow TJ (1990) An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Mol Brain Res 7:273–276
Parchi P, Chen SG, Brown P, Zou WQ, Capellari S, Budka H, Hainfellner J, Reyes PF, Golden GT, Hauw J-J, et al (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci USA 95:8322–8328
Parchi P, Petersen RB, Chen SG, Autillo-Gambetti L, Capellari S, Monari L, Cortelli P, Montagna P, Lugaresi E, Gambetti P (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8:539–548
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233
Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wüthrich K (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci USA 95:11667–11672
Rogers M, Taraboulos A, Scott M, Groth D, Prusiner SB (1990) Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1:101–109
Rudd PM, Wormald MR, Wing DR, Prusiner SB, Dwek RA (2001) Prion glycoprotein: structure, dynamics, and roles for the sugars. Biochemistry 40:3759–3766
Silvestrini MC, Cardone F, Maras B, Pucci P, Barra D, Brunori M, Pocchiari M (1997) Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeld-Jakob disease patients. Nat Med 3:521–525
Tagliavini F, Prelli F, Porro M, Rossi G, Giaccone G, Farlow MR, Dlouhy SR, Ghetti B, Bugiani O, Frangione B (1994) Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79:695–704
Vorberg I, Buschmann A, Harmeyer S, Saalmüller A, Pfaff E, Groschup M (1999) A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology 255:26–31
Windl O, Dempster M, Estibeiro JP, Lathe R, De Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KCL, Palmer MS, Collinge J (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variations in the PRNP gene. Hum Genet 98:259–264
Windl O, Giese A, Schulz-Schaeffer W, Skworc K, Arendt S, Oberdieck C, Bodemer M, Zerr I, Poser S, Kretzschmar HA (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105:244–252
Young K, Clark HB, Piccardo P, Dlouhy SR, Ghetti B (1997) Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Mol Brain Res 44:147–150
Zahn R, Liu A, Luhrs T, Riek R, Schroetter C von, Lopez GF, Billeter M, Calzolai L, Wider G, Wuthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145–150
Acknowledgements
This study was supported by the Federal Ministry of Health (325-4471–02/15). Dr. R. Lederer is gratefully acknowledged for help in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grasbon-Frodl, E., Lorenz, H., Mann, U. et al. Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol 108, 476–484 (2004). https://doi.org/10.1007/s00401-004-0913-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-004-0913-4